HIGHLIGHTS
- who: FangJie Liu and collaborators from the Shandong Cancer Hospital, China Loyola University Chicago have published the research: Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients, in the Journal: (JOURNAL)
- what: The aims of this study were two-fold: (a) to investigate the relationship between longitudinal TLC changes and survival outcome in LA-NSCLC patients undergoing definitive CCRT and_(b) to evaluate the clinical factors associated with persistent lymphopenia induced by CCRT in the patient population. The primary endpoint of the study was overall . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.